BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 26920015)

  • 1. GABAA receptor-mediated neurotransmission: Not so simple after all.
    Knoflach F; Hernandez MC; Bertrand D
    Biochem Pharmacol; 2016 Sep; 115():10-7. PubMed ID: 27002180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
    Yousuf MS; Zubkow K; Tenorio G; Kerr B
    Neuroscience; 2017 Mar; 344():178-186. PubMed ID: 28057537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Schizophrenia With the Diuretic Bumetanide: A Case Report.
    Lemonnier E; Lazartigues A; Ben-Ari Y
    Clin Neuropharmacol; 2016; 39(2):115-7. PubMed ID: 26966887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function missense variant in SLC12A2, encoding the bumetanide-sensitive NKCC1 cotransporter, identified in human schizophrenia.
    Merner ND; Mercado A; Khanna AR; Hodgkinson A; Bruat V; Awadalla P; Gamba G; Rouleau GA; Kahle KT
    J Psychiatr Res; 2016 Jun; 77():22-6. PubMed ID: 26955005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early IGF-1 primes visual cortex maturation and accelerates developmental switch between NKCC1 and KCC2 chloride transporters in enriched animals.
    Baroncelli L; Cenni MC; Melani R; Deidda G; Landi S; Narducci R; Cancedda L; Maffei L; Berardi N
    Neuropharmacology; 2017 Feb; 113(Pt A):167-177. PubMed ID: 26924708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinhibition, an emerging pharmacology of learning and memory.
    Möhler H; Rudolph U
    F1000Res; 2017; 6():. PubMed ID: 28232865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly specific σ
    Yousuf MS; Sahn JJ; Yang H; David ET; Shiers S; Mancilla Moreno M; Iketem J; Royer DM; Garcia CD; Zhang J; Hong VM; Mian SM; Ahmad A; Kolber BJ; Liebl DJ; Martin SF; Price TJ
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2306090120. PubMed ID: 38117854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly specific σ
    Yousuf MS; Sahn JJ; Yang H; David ET; Shiers S; Moreno MM; Iketem J; Royer DM; Garcia CD; Zhang J; Hong VM; Mian SM; Ahmad A; Kolber BJ; Liebl DJ; Martin SF; Price TJ
    bioRxiv; 2023 Oct; ():. PubMed ID: 37090527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NKCC1 in spinal dorsal horn and dorsal root ganglion results in alleviation of neuropathic pain in rats with spinal cord contusion.
    Wu Y; Wang F
    Mol Pain; 2023; 19():17448069231159855. PubMed ID: 36760008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.
    Temmermand R; Barrett JE; Fontana ACK
    Pharmacol Res; 2022 Nov; 185():106492. PubMed ID: 36228868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of (
    Abram M; Jakubiec M; Reeb K; Cheng MH; Gedschold R; Rapacz A; Mogilski S; Socała K; Nieoczym D; Szafarz M; Latacz G; Szulczyk B; Kalinowska-Tłuścik J; Gawel K; Esguerra CV; Wyska E; Müller CE; Bahar I; Fontana ACK; Wlaź P; Kamiński RM; Kamiński K
    J Med Chem; 2022 Sep; 65(17):11703-11725. PubMed ID: 35984707
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of Spinal ASIC1 and NKCC1 Expression Contributes to Chronic Visceral Pain in Rats.
    Li YC; Tian YQ; Wu YY; Xu YC; Zhang PA; Sha J; Xu GY
    Front Mol Neurosci; 2020; 13():611179. PubMed ID: 33584200
    [No Abstract]   [Full Text] [Related]  

  • 13. Substance P and pain chronicity.
    Zieglgänsberger W
    Cell Tissue Res; 2019 Jan; 375(1):227-241. PubMed ID: 30284083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced GABAergic neuronal activity in zona incerta causes neuropathic pain in a rat sciatic nerve chronic constriction injury model.
    Moon HC; Park YS
    J Pain Res; 2017; 10():1125-1134. PubMed ID: 28546770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Regulatory Transporters in Neuropathic Pain.
    Yousuf MS; Kerr BJ
    Adv Pharmacol; 2016; 75():245-71. PubMed ID: 26920015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The etiological contribution of GABAergic plasticity to the pathogenesis of neuropathic pain.
    Li C; Lei Y; Tian Y; Xu S; Shen X; Wu H; Bao S; Wang F
    Mol Pain; 2019; 15():1744806919847366. PubMed ID: 30977423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-synaptic switches of GABA actions associated with Cl- homeostatic changes are induced in the spinal nucleus of the trigeminal nerve in a rat model of trigeminal neuropathic pain.
    Wei B; Kumada T; Furukawa T; Inoue K; Watanabe M; Sato K; Fukuda A
    Neuroscience; 2013 Jan; 228():334-48. PubMed ID: 23103796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glutamatergic system as a target for neuropathic pain relief.
    Osikowicz M; Mika J; Przewlocka B
    Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressing SNAP-25 and reversing glial glutamate transporters relieves neuropathic pain in rats by ameliorating imbalanced neurotransmission.
    Liu C; Guo QL; Huang CS; Zou WY; Song ZB
    Chin Med J (Engl); 2013 Nov; 126(21):4100-4. PubMed ID: 24229681
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.